Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
about
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene expression signature base ...... eutic target in Ewing sarcoma.
@en
Gene expression signature base ...... eutic target in Ewing sarcoma.
@nl
type
label
Gene expression signature base ...... eutic target in Ewing sarcoma.
@en
Gene expression signature base ...... eutic target in Ewing sarcoma.
@nl
prefLabel
Gene expression signature base ...... eutic target in Ewing sarcoma.
@en
Gene expression signature base ...... eutic target in Ewing sarcoma.
@nl
P2860
P356
P1433
P1476
Gene expression signature base ...... peutic target in Ewing sarcoma
@en
P2093
Kelli L Goss
P2860
P304
63003-63019
P356
10.18632/ONCOTARGET.11416
P407
P577
2016-09-01T00:00:00Z